Evidence map›Paper›PMID 42145224›Full record

ReviewParasite immunology2026

Exploring the Role of the MAPK Signalling Pathway in Dog Immunity: From Cancer to Parasitic Diseases.

Francini Neves Ribeiro, Fernanda Nazaré Morgado, Renato Porrozzi

Abstract readReview
In one paragraph

Review in Parasite immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francini Neves RibeiroLaboratório de Protozoologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.ORCID 0000-0002-1379-5549
Fernanda Nazaré MorgadoLaboratório de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.ORCID 0000-0002-7188-251X
Renato PorrozziLaboratório de Protozoologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.ORCID 0000-0003-2167-316X

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico - PROEP - IOC 441708/2024Conselho Nacional de Desenvolvimento Científico e Tecnológico - PROEP - IOC 442053/2024-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance code 001Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/204.308/2024Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/211.340/2021
6 · The paper itself

Abstract

Mitogen-activated protein kinases (MAPKs) are intracellular signalling proteins that modulate several cellular processes, such as proliferation, cytokine production and survival. Like humans, dogs may exhibit changes in MAPK signalling under pathological conditions. Alterations in this pathway have been observed in several types of cancers in dogs and have been widely studied in veterinary oncology. In humans, several studies have focused on the MAPK pathway in cancer, inflammatory diseases and parasitic diseases; however, the role of the MAPK pathway in parasitic diseases has not been extensively explored in canine models. Some parasites use these proteins as strategic targets for modulating the immune response to ensure their survival and persistence in host cells. Although they have distinct pathogeneses, some mechanisms of immune system evasion are shared between parasites and cancer cells. The aim of this review is to discuss the MAPK pathway involvement in the immune system and in inflammatory and parasitic disease in dogs.

Indexed as

Dog DiseasesMAP Kinase Signaling SystemMitogen-Activated Protein KinasesNeoplasmsParasitic Diseases, AnimalSignal TransductionAnimalsDogsMitogen-Activated Protein Kinasescancercell signallingdogsimmune systemMAPK pathwayparasite survivalparasitic disease

Identifiers

PMID42145224
PMCPMC13181708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.